Literature DB >> 11239563

Vasopeptidase inhibitors: an emerging class of cardiovascular drugs.

J Bralet, J C Schwartz.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11239563     DOI： 10.1016/s0165-6147(00)01644-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  8 in total

Review 1.  Heart failure in 10 years time: focus on pharmacological treatment.

Authors:  J J V McMurray
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

2.  An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors.

Authors:  Nishi K Rao; Arpita Yadav; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2009-05-09       Impact factor: 1.810

3.  Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin.

Authors:  Christiane Rose; Stéphanie Voisin; Claude Gros; Jean-Charles Schwartz; Tanja Ouimet
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

4.  Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure.

Authors:  Toshiyuki Maki; Yoshihisa Nasa; Kouichi Tanonaka; Masaya Takahashi; Satoshi Takeo
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

5.  Biosynthesis, processing, trafficking, and enzymatic activity of mouse neprilysin 2.

Authors:  Kentaro Oh-hashi; Kazumi Ohkubo; Kaoru Shizu; Hibiki Fukuda; Yoko Hirata; Kazutoshi Kiuchi
Journal:  Mol Cell Biochem       Date:  2008-04-19       Impact factor: 3.396

6.  Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist.

Authors:  Luz E Tavera-Mendoza; Tan D Quach; Basel Dabbas; Jonathan Hudon; Xiaohong Liao; Ana Palijan; James L Gleason; John H White
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

Review 7.  New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection.

Authors:  A J Turner; N N Nalivaeva
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

8.  Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

Authors:  Florian Gembardt; Anja Sterner-Kock; Hans Imboden; Matthias Spalteholz; Franziska Reibitz; Heinz-Peter Schultheiss; Wolf-Eberhard Siems; Thomas Walther
Journal:  Peptides       Date:  2005-02-16       Impact factor: 3.750
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.